CANNPICO

Welcome to the Brand page for “CANNPICO”, which is offered here for The mark consists of an image of a stylized cannabis leaf in green with a snake in light green coiled around a vertical light green staff (representing the rod of asclepius) and the wording cannpico in green to the right of the design.;pharmaceuticals for the treatment of anxiety, including post-traumatic stress disorder, epilepsy, schizophrenia and other psychiatric disorders, chronic and neuropathic pain, neurodegenerative disorders, tumors, diabetes, movement disorders and anti-spastic treatment, drug abuse, including withdrawal treatment, covid-19 related lung inflammation, oxidative stress, and skin diseases; none of the foregoing comprised of cannabis sativa l with a delta-9 tetrahydrocannabinol (thc) content of more than 0.3 percent on a dry weight basis;cosmetics and cosmetic preparations, none of the foregoing comprised of cannabis sativa l with a delta-9 tetrahydrocannabinol (thc) content of more than 0.3 percent on a dry weight basis;the color(s) light green and green is/are claimed as a feature of the mark.;wholesale services, ordering services and direct solicitation by sales agents and distributors for pharmaceutical, cosmetics and cosmetic preparations with none of the foregoing comprised of cannabis sativa l with a delta-9 tetrahydrocannabinol (thc) content of more than 0.3 percent on a dry weight basis; advertising services in relation to cosmetics, cosmetic preparations, and pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “CANNPICO” is believed to be currently owned by “CannPico Research & Marketingservice GmbH”.

Owner:
CANNPICO RESEARCH & MARKETINGSERVICE GMBH
Owner Details
Description:
The mark consists of an image of a stylized cannabis leaf in green with a snake in light green coiled around a vertical light green staff (representing the Rod of Asclepius) and the wording CannPico in green to the right of the design.;Pharmaceuticals for the treatment of anxiety, including post-traumatic stress disorder, epilepsy, schizophrenia and other psychiatric disorders, chronic and neuropathic pain, neurodegenerative disorders, tumors, diabetes, movement disorders and anti-spastic treatment, drug abuse, including withdrawal treatment, COVID-19 related lung inflammation, oxidative stress, and skin diseases; none of the foregoing comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis;Cosmetics and cosmetic preparations, none of the foregoing comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis;The color(s) light green and green is/are claimed as a feature of the mark.;Wholesale services, ordering services and direct solicitation by sales agents and distributors for pharmaceutical, cosmetics and cosmetic preparations with none of the foregoing comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis; advertising services in relation to cosmetics, cosmetic preparations, and pharmaceuticals;
Categories: